Showing results (301-310 of 366) with videos related to

Sort By:
Pageof 37
Critical Care Medicine|July 14, 2021
Descriptors of Sepsis Using the Sepsis-3 Criteria: A Cohort Study in Critical Care Units Within the U.K. National Institute for Health Research Critical Care Health Informatics CollaborativeAnoop D Shah, Niall S MacCallum, Steve Harris, et al.
Critical Care (London, England)|October 24, 2017
Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational studyJohannes Ehler, Lucinda K Barrett, Valerie Taylor, et al.
Antibiotics (Basel, Switzerland)|October 28, 2025
Peri-Operative Antimicrobial Prophylaxis Modulates CD4+ Lymphocyte Immunophenotype Ex Vivo in High-Risk Patients Undergoing Major Elective Surgery-A Preliminary Observational StudySusi Paketci, Jack Williams, Walter Pisciotta, et al.
Critical Care Medicine|May 23, 2008
Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care MedicinePaul E Marik, Stephen M Pastores, Djillali Annane, et al.
Plos Medicine|July 6, 2017
Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury modelsAlex Dyson, Felipe Dal-Pizzol, Giovanni Sabbatini, et al.
The Lancet. Respiratory Medicine|December 20, 2014
Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trialGareth L Ackland, Sadaf Iqbal, Laura Gallego Paredes, et al.
Trials|March 2, 2021
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trialJan Maláska, Jan Stašek, František Duška, et al.
Trials|January 16, 2022
Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trialJan Maláska, Jan Stašek, František Duška, et al.
Molecular and Cellular Biochemistry|August 4, 2019
A key metabolic integrator, coenzyme A, modulates the activity of peroxiredoxin 5 via covalent modificationJovana Baković, Bess Yi Kun Yu, Daniel Silva, et al.
Critical Care Explorations|August 13, 2021
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center CohortNishkantha Arulkumaran, Timothy Arthur Chandos Snow, Adarsh Kulkarni, et al.
Pageof 37